Clinical trial NCT04914000: Motivating a Spectrum of Cancer Patients to Quit Smoking
Official title: Motivating a Spectrum of Cancer Patients to Quit Smoking: Intervention Development and Feasibility
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Cancer
Smoking
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sponsor class: OTHER
Collaborators: name: National Cancer Institute (NCI)
First posted: 2021-06-04
Enrollment: 53
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: PREVENTION

Brief summary: This study will assess feasibility and acceptability of an intervention designed to increase smoking cessation motivation among patients with a cancer not widely known to be smoking related.


Eligibility criteria: Inclusion Criteria:

* Smoking at least 1 cigarette in previous 30 days
* Diagnosis of breast, colorectal, gynecological, skin melanoma, or bladder cancer within the last 6 months
* Able to read/write English
* Able to give informed consent
* Not currently enrolled in a smoking cessation program

Exclusion Criteria:

* Having distant metastases
* Male patients with breast cancer

Primary outcomes:
measure: Number of Participants Who Consent to Participate in the Study- Feasibility
timeFrame: Baseline
measure: Number of Participants That Complete 1-week Follow-up Assessments - Feasibility
timeFrame: 1-week post-treatment
measure: Number of Participants That Complete 1 Month Follow-up Assessments - Feasibility
timeFrame: 1-month post-treatment
measure: Number of Participants Who Read the Booklet - Demand - 1 Week Post Treatment
timeFrame: 1-week post-treatment
measure: Number of Participants Who Read the Booklet - Demand - 1 Month Post Treatment
timeFrame: 1-month post-treatment
measure: Acceptability
timeFrame: 1-month post-treatment
Secondary outcomes:
measure: Motivation to Quit Smoking Assessed With the Contemplation Ladder
timeFrame: Baseline, 1-week post-treatment, 1-month post-treatment
measure: Motivation to Quit Smoking Assessed With the Short Form of the Smoking Abstinence-related Motivational Engagement (ARME).
timeFrame: Baseline, 1-week post-treatment, 1-month post-treatment
measure: Participants Change in Motivation - Action Stage
timeFrame: Baseline, at 1 week and 1 month post treatment
measure: Motivation to Quit Smoking Assessed With the Number of Visits to the Study Website
timeFrame: 1-month post-treatment
measure: Motivation to Quit Smoking Assessed by Contact With the Tobacco Treatment Specialist - 1 Week
timeFrame: At 1 Week Post Treatment
measure: Motivation to Quit Smoking Assessed by Contact With the Tobacco Treatment Specialist - 1 Month
timeFrame: At 1 Month Post Treatment
measure: Participants That Had a Quit Attempt - 1 Week
timeFrame: At 1 Week Post Treatment
measure: Participants That Had a Quit Attempt - 1 Month
timeFrame: At 1 Month Post Treatment
measure: Motivation to Quit Smoking Assessed With the Number of Quit Attempts - 1 Month
timeFrame: At 1 Month Post Treatment
measure: Number of Participants Reporting 7-day Point Prevalence Abstinence
timeFrame: 1-week post-treatment
measure: Number of Participants Reporting 30-day Point Prevalence Abstinence
timeFrame: 1-month post-treatment
Other outcomes:
Locations:
city: Tampa
country: United States
facility: Moffitt Cancer Center
state: Florida
Study officials:
affiliation: Moffitt Cancer Center
name: Ursula Martinez, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References: